IPSC
Century Therapeutics Inc
1.50$
-3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.7% | 49.1% | 57.3% | 48.9% | 53.0% | 54.9% | 53.7% | 56.3% | 56.3% | 54.0% | 42.6% | 43.5% | |
| 13.9% | 13.1% | 13.4% | 10.0% | 13.5% | 16.5% | 16.4% | 20.0% | 22.7% | 27.6% | 15.6% | 17.3% | |
| 42.6% | 47.9% | 55.1% | 47.2% | 51.0% | 53.6% | 52.3% | 54.7% | 54.2% | 52.4% | 41.3% | 41.7% | |
| 0.4% | 0.2% | – | 0.4% | 0.3% | 0.4% | 0.3% | 0.2% | 0.2% | 0.3% | – | – | |
| -0.4% | – | – | – | -0.3% | – | – | – | – | – | – | – | |
| – | – | – | 1.2% | 1.2% | – | – | – | – | – | – | – | |
| – | – | – | 8.0% | 8.7% | 9.7% | 10.8% | 12.0% | 14.0% | 15.3% | 10.5% | 11.9% | |
| 44.9% | 48.8% | 49.0% | 46.7% | 49.6% | 54.3% | 23.8% | 26.3% | 27.9% | 29.0% | 18.9% | 19.0% | |
| 5.1% | 4.9% | 4.6% | 4.6% | 5.1% | 36.7% | 4.6% | 5.3% | 9.0% | 9.0% | 4.2% | 5.3% | |
| 0.5% | 0.4% | 0.6% | 0.9% | 1.0% | 1.4% | 1.5% | 1.7% | 1.5% | 1.5% | 1.3% | – | |
| 1.5% | 0.8% | 1.0% | 0.8% | 0.7% | 0.9% | 1.1% | 1.1% | 1.1% | 2.1% | 1.0% | 1.7% | |
| 55.1% | 51.2% | 51.0% | 53.3% | 50.4% | 45.7% | 76.2% | 73.7% | 72.1% | 71.0% | 81.1% | 81.0% | |
| -155.0% | -181.8% | -196.2% | -171.7% | -192.0% | -221.5% | -223.6% | -259.3% | -315.8% | -354.0% | -249.1% | -295.5% | |
| 15.0% | 16.6% | 17.9% | 19.7% | 21.8% | 22.3% | 27.3% | 30.3% | 35.3% | 38.7% | 26.5% | 71.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.